ABAT was negatively correlated with almost all immunosuppressive factors, such as CTLA4, LGALS9, and TGFB1 in HCC, indicating that ABAT expression might be associated with the efficacy of immunotherapy in HCC. This evidence concerns the gene LGALS9 and hepatocellular carcinoma.